We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Targeting vulnerable atherosclerotic plaque via PET-tracers aiming at cell-surface overexpression of somatostatin receptors.
- Authors
Z. Papadakis, Georgios; Kochiadakis, George; Lazopoulos, George; Marias, Kostas; Klapsinos, Nikolaos; Hannah-Shmouni, Fady; G. Igoumenaki, Georgia; Konstantinos Nikolouzakis, Taxiarchis; Kteniadakis, Stelios; A. Spandidos, Demetrios; H. Karantanas, Apostolos
- Abstract
Cardiovascular disease (CD) is the leading cause of death in the developed world, with major atherothrombotic events, being mainly attributed to the rupture of unstable, vulnerable atherosclerotic lesions, leading to blood flow obstruction. Since unstable atherosclerotic plaques frequently do not cause hemodynamically significant blood flow restriction, conventional stress imaging tests cannot depict the vulnerable, high-risk for rupture atherosclerotic lesions. Therefore, molecular imaging techniques targeting specific pathophysiologic features related to atherosclerotic plaque rupture mechanism, hold promise for precise and individualized treatment strategies of CD. In the current report, we describe in a patient diagnosed with pancreatic neuroendocrine tumor, the selective uptake of 68Ga-DOATATE by an atherosclerotic lesion in the thoracic aorta. This data indicates that 68Ga-DOTATATE, which is a positron emitting tomography tracer, targeting the recruitment of macrophages taking place in the vulnerable plaque, could potentially serve as an imaging probe for the detection of high-risk, prone to rupture plaques.
- Subjects
SOMATOSTATIN receptors; ATHEROSCLEROTIC plaque; BLOOD flow; THORACIC aorta; PANCREATIC tumors; NEUROENDOCRINE tumors
- Publication
Biomedical Reports, 2020, Vol 13, Issue 3, pN.PAG
- ISSN
2049-9434
- Publication type
Article
- DOI
10.3892/br.2020.1316